193 related articles for article (PubMed ID: 8302285)
1. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
Aharony D; Little J; Powell S; Hopkins B; Bundell KR; McPheat WL; Gordon RD; Hassall G; Hockney R; Griffin R
Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery.
Aharony D; Little J; Thomas C; Powell S; Downey-Jones M; Graham A
J Recept Res; 1994 Dec; 14(6-8):399-421. PubMed ID: 7877137
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of the novel ligand [4,5-3H-Leu9]neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes.
Aharony D; Conner GE; Woodhouse DP
Neuropeptides; 1992 Oct; 23(2):121-30. PubMed ID: 1333574
[TBL] [Abstract][Full Text] [Related]
5. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents.
Aharony D; Catanese CA; Woodhouse DP
J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
Aharony D; Buckner CK; Ellis JL; Ghanekar SV; Graham A; Kays JS; Little J; Meeker S; Miller SC; Undem BJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1216-21. PubMed ID: 7562491
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Engberg S; Ahlstedt I; Leffler A; Lindström E; Kristensson E; Svensson A; Påhlman I; Johansson A; Drmota T; von Mentzer B
Biochem Pharmacol; 2007 Jan; 73(2):259-69. PubMed ID: 17097619
[TBL] [Abstract][Full Text] [Related]
9. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
10. Expression of rat NK-2 (neurokinin A) receptor in E. coli.
Grisshammer R; Little J; Aharony D
Recept Channels; 1994; 2(4):295-302. PubMed ID: 7719707
[TBL] [Abstract][Full Text] [Related]
11. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
Mussap CJ; Burcher E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
[TBL] [Abstract][Full Text] [Related]
12. Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.
Gembitsky DS; Murnin M; Otvös FL; Allen J; Murphy RF; Lovas S
J Med Chem; 1999 Jul; 42(15):3004-7. PubMed ID: 10425111
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
Warner FJ; Comis A; Miller RC; Burcher E
Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin NK-2 receptors in child urinary bladder.
Zeng XP; Burcher E
J Urol; 1996 Mar; 155(3):1104-7. PubMed ID: 8583573
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.
Kudlacz EM; Shatzer SA; Knippenberg RW; Logan DE; Poirot M; van Giersbergen PL; Burkholder TP
J Pharmacol Exp Ther; 1996 May; 277(2):840-51. PubMed ID: 8627566
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction mechanisms of recombinant bovine neurokinin-2 receptor stably expressed in baby hamster kidney cells.
Eistetter HR; Mills A; Arkinstall SJ
J Cell Biochem; 1993 May; 52(1):84-91. PubMed ID: 8391539
[TBL] [Abstract][Full Text] [Related]
18. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
Bergström L; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; Lavielle S; Chassaing G; Marquet A; D'Orleans-Juste P; Dion S
Mol Pharmacol; 1987 Dec; 32(6):764-71. PubMed ID: 2826990
[TBL] [Abstract][Full Text] [Related]
19. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
20. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
